In case you don't speak french see below. GREAT !!!! A company based in Orleans, near Ottawa, is experiencing a significant growth in the development of medical cannabis. This biopharmaceutical company wants to make cannabis and cannabinoid products part of the Canadian medical system.
Tetra-Bio Pharma is the only company in North America to work with Health Canada and the US Food and Drug Administration (FDA) to conduct clinical trials that meet the requirements of all such as regulatory agencies, physicians and insurers.
"The standard is being set," says biopharmaceutical CEO Guy Chamberland. "Agencies are shown to be able to develop a cannabis drug with the same rigor as any other drug on the market. "
A drug marketed by Health Canada and the FDA has a greater level of reliability than a cannabis-based recreational product whose doses can fluctuate and whose interactions with other drugs have not been analyzed, recalls the CEO.
Pharmacists and researchers are conducting a study on the effects of inhaled cannabis medications on pain. Phase 1 of the study shows conclusive results, according to Chamberland.
"The pharmacodynamic effect is very well demonstrated. We see it within 4-5 minutes, "says Chamberland. "A maximum threshold of THC detaches [patients] from suffering. "